[1] Z. Miao, Z. Gao, R. Chen, X. Yu, Z. Su, G. Wei, Surface-bioengineered gold nanoparticles for biomedical applications, Curr. Med. Chem. 25 (2018). https://doi.org/10.2174/0929867325666180117111404.
[2] H. Jahangirian, K. Kalantari, Z. Izadiyan, R. Rafiee-Moghaddam, K. Shameli, T.J. Webster, <p>A review of small molecules and drug delivery applications using gold and iron nanoparticles</p>, Int. J. Nanomedicine. Volume 14 (2019) 1633–1657. https://doi.org/10.2147/IJN.S184723.
[3] P. Kumar, P. Shivam, S. Mandal, P. Prasanna, S. Kumar, S.R. Prasad, A. Kumar, P. Das, V. Ali, S.K. Singh, D. Mandal, <p>Synthesis, characterization, and mechanistic studies of a gold nanoparticle–amphotericin B covalent conjugate with enhanced antileishmanial efficacy and reduced cytotoxicity</p>, Int. J. Nanomedicine. Volume 14 (2019) 6073–6101. https://doi.org/10.2147/IJN.S196421.
[4] S. Das, P. Roy, S. Mondal, T. Bera, A. Mukherjee, One pot synthesis of gold nanoparticles and application in chemotherapy of wild and resistant type visceral leishmaniasis, Colloids Surfaces B Biointerfaces. 107 (2013) 27–34. https://doi.org/10.1016/j.colsurfb.2013.01.061.
[5] S. Wu, X. Yang, F. Luo, T. Wu, P. Xu, M. Zou, J. Yan, Biosynthesis of flower-shaped Au nanoclusters with EGCG and their application for drug delivery, J. Nanobiotechnology. 16 (2018) 1–14. https://doi.org/10.1186/s12951-018-0417-3.
[6] A. Graczyk, R. Pawlowska, D. Jedrzejczyk, A. Chworos, Gold nanoparticles in conjunction with nucleic acids as a modern molecular system for cellular delivery, Molecules. 25 (2020). https://doi.org/10.3390/molecules25010204.
[7] S. Yadav, A.K. Sharma, P. Kumar, Nanoscale Self-Assembly for Therapeutic Delivery, Front. Bioeng. Biotechnol. 8 (2020). https://doi.org/10.3389/fbioe.2020.00127.
[8] G.R. Rudramurthy, M.K. Swamy, U.R. Sinniah, A. Ghasemzadeh, Nanoparticles: Alternatives against drug-resistant pathogenic microbes, Molecules. 21 (2016). https://doi.org/10.3390/molecules21070836.
[9] M.N. Uddin, F. Desai, E. Asmatulu, Engineered nanomaterials in the environment: bioaccumulation, biomagnification and biotransformation, Environ. Chem. Lett. (2020) 1–11. https://doi.org/10.1007/s10311-019-00947-0.
[10] A.K. Mittal, Y. Chisti, U.C. Banerjee, Synthesis of metallic nanoparticles using plant extracts, Biotechnol. Adv. 31 (2013) 346–356. https://doi.org/10.1016/j.biotechadv.2013.01.003.
[11] M. Das, S. Chatterjee, Green synthesis of metal/metal oxide nanoparticles toward biomedical applications: Boon or bane, in: Green Synth. Charact. Appl. Nanoparticles, Elsevier, 2019: pp. 265–301. https://doi.org/10.1016/b978-0-08-102579-6.00011-3.
[12] H. Agarwal, S. Venkat Kumar, S. Rajeshkumar, A review on green synthesis of zinc oxide nanoparticles – An eco-friendly approach, Resour. Technol. 3 (2017) 406–413. https://doi.org/10.1016/j.reffit.2017.03.002.
[13] J. Singh, T. Dutta, K.H. Kim, M. Rawat, P. Samddar, P. Kumar, “Green” synthesis of metals and their oxide nanoparticles: Applications for environmental remediation, J. Nanobiotechnology. 16 (2018) 1–24. https://doi.org/10.1186/s12951-018-0408-4.
[14] Q. Han, X. Wang, S. Cai, X. Liu, Y. Zhang, L. Yang, C. Wang, R. Yang, Quercetin nanoparticles with enhanced bioavailability as multifunctional agents toward amyloid induced neurotoxicity, J. Mater. Chem. B. 6 (2018) 1387–1393. https://doi.org/10.1039/c7tb03053c.
[15] S. Mukherjee, S. Ghosh, D.K. Das, P. Chakraborty, S. Choudhury, P. Gupta, A. Adhikary, S. Dey, S. Chattopadhyay, Gold-conjugated green tea nanoparticles for enhanced anti-tumor activities and hepatoprotection - synthesis, characterization and in vitro evaluation, J. Nutr. Biochem. 26 (2015) 1283–1297. https://doi.org/10.1016/j.jnutbio.2015.06.003.
[16] P. Thamaket, P. Raviyan, Preparation and physical properties of carotenoids encapsulated in chitosan cross-linked tripolyphosphate nanoparticles, 3 (2015) 69–84.
[17] S. Jain, M.S. Mehata, Medicinal Plant Leaf Extract and Pure Flavonoid Mediated Green Synthesis of Silver Nanoparticles and their Enhanced Antibacterial Property, Sci. Rep. 7 (2017). https://doi.org/10.1038/s41598-017-15724-8.
[18] G. Marslin, K. Siram, Q. Maqbool, R.K. Selvakesavan, D. Kruszka, P. Kachlicki, G. Franklin, Secondary metabolites in the green synthesis of metallic nanoparticles, Materials (Basel). 11 (2018) 1–25. https://doi.org/10.3390/ma11060940.
[19] G.L. Hostetler, R.A. Ralston, S.J. Schwartz, Flavones: Food Sources, Bioavailability, Metabolism, and Bioactivity, Adv. Nutr. An Int. Rev. J. 8 (2017) 423–435. https://doi.org/10.3945/an.116.012948.
[20] A.N. Panche, A.D. Diwan, S.R. Chandra, Flavonoids: An overview, J. Nutr. Sci. 5 (2016). https://doi.org/10.1017/jns.2016.41.
[21] V. Gopinath, S. Priyadarshini, M. Fai, J. Arunkumar, E. Marsili, D. Mubarakali, P. Velusamy, J. Vadivelu, Biogenic synthesis , characterization of antibacterial silver nanoparticles and its cell cytotoxicity, Arab. J. Chem. 10 (2017) 1107–1117. https://doi.org/10.1016/j.arabjc.2015.11.011.
[22] X. Li, W. Luo, T.W. Ng, P.C. Leung, C. Zhang, K.C.F. Leung, L. Jin, Nanoparticle-encapsulated baicalein markedly modulates pro-inflammatory response in gingival epithelial cells, Nanoscale. 9 (2017) 12897–12907. https://doi.org/10.1039/c7nr02546g.
[23] M. Hussain, N.I. Raja, M. Iqbal, S. Aslam, Applications of Plant Flavonoids in the Green Synthesis of Colloidal Silver Nanoparticles and Impacts on Human Health Applications of Plant Flavonoids in the Green Synthesis of Colloidal Silver Nanoparticles and Impacts on Human Health, Iran. J. Sci. Technol. Trans. A Sci. (2017). https://doi.org/10.1007/s40995-017-0431-6.
[24] L.G. Sarbu, L.G. Bahrin, C. Babii, M. Stefan, M.L. Birsa, Synthetic flavonoids with antimicrobial activity: a review, J. Appl. Microbiol. 127 (2019) 1282–1290. https://doi.org/10.1111/jam.14271.
[25] F. Chappuis, S. Sundar, A. Hailu, H. Ghalib, S. Rijal, R.W. Peeling, J. Alvar, M. Boelaert, Visceral leishmaniasis: What are the needs for diagnosis, treatment and control?, Nat. Rev. Microbiol. 5 (2007) 873–882. https://doi.org/10.1038/nrmicro1748.
[26] M. Tullius Scotti, L. Scotti, H. Ishiki, F. Fávaro Ribeiro, R. Marques Duarte da Cruz, M. Pedrosa de Oliveira, F. Jaime Bezerra Mendonça, Natural Products as a Source for Antileishmanial and Antitrypanosomal Agents, Comb. Chem. High Throughput Screen. 19 (2016) 537–553. https://doi.org/10.2174/1386207319666160506123921.
[27] P.K. Boniface, E.I. Ferreira, Flavonoids as efficient scaffolds: Recent trends for malaria, leishmaniasis, Chagas disease, and dengue, Phyther. Res. 33 (2019) 2473–2517. https://doi.org/10.1002/ptr.6383.
[28] D. Tasdemir, M. Kaiser, R. Brun, V. Yardley, T.J. Schmidt, F. Tosun, P. Ru, Antitrypanosomal and Antileishmanial Activities of Flavonoids and Their Analogues : In Vitro , In Vivo , Structure-Activity Relationship , and Quantitative Structure-Activity Relationship Studies, 50 (2006) 1352–1364. https://doi.org/10.1128/AAC.50.4.1352.
[29] P.M. Cheuka, G. Mayoka, P. Mutai, K. Chibale, The role of natural products in drug discovery and development against neglected tropical diseases, Molecules. 22 (2017). https://doi.org/10.3390/molecules22010058.
[30] C. Liu, C.B. Chan, K. Ye, 7,8-dihydroxyflavone, a small molecular TrkB agonist, is useful for treating various BDNF-implicated human disorders, Transl. Neurodegener. 5 (2016). https://doi.org/10.1186/s40035-015-0048-7.
[31] X. Han, S. Zhu, B. Wang, L. Chen, R. Li, W. Yao, Z. Qu, Antioxidant action of 7,8-dihydroxyflavone protects PC12 cells against 6-hydroxydopamine-induced cytotoxicity, Neurochem. Int. 64 (2014) 18–23. https://doi.org/10.1016/j.neuint.2013.10.018.
[32] Z. Jin, Y.Z. Yang, J.X. Chen, Y.Z. Tang, Inhibition of pro-inflammatory mediators in RAW264.7 cells by 7-hydroxyflavone and 7,8-dihydroxyflavone, J. Pharm. Pharmacol. 69 (2017) 865–874. https://doi.org/10.1111/jphp.12714.
[33] P.P. Carneiro, J. Conceição, M. Macedo, V. Magalhães, E.M. Carvalho, O. Bacellar, The role of nitric oxide and reactive oxygen species in the killing of Leishmania braziliensis by monocytes from patients with cutaneous leishmaniasis, PLoS One. 11 (2016). https://doi.org/10.1371/journal.pone.0148084.
[34] B. Purkait, A. Kumar, N. Nandi, A.H. Sardar, S. Das, S. Kumar, K. Pandey, V. Ravidas, M. Kumar, T. De, D. Singh, P. Das, Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani, Antimicrob. Agents Chemother. 56 (2012) 1031–1041. https://doi.org/10.1128/AAC.00030-11.
[35] J.J.M. De Llano, E.J. Andreu, A. Pastor, M. De La Guardia, E. Knecht, Electrothermal atomic absorption spectrometric diagnosis of familial hypercholesterolemia, Anal. Chem. 72 (2000) 2406–2413. https://doi.org/10.1021/ac991287p.
[36] Y. Xiao, W. Xu, Y. Komohara, Y. Fujiwara, H. Hirose, S. Futaki, T. Niidome, Effect of Surface Modifications on Cellular Uptake of Gold Nanorods in Human Primary Cells and Established Cell Lines, ACS Omega. 5 (2020) 32744–32752. https://doi.org/10.1021/acsomega.0c05162.
[37] J. Trono, K. Mizuno, N. Yusa, T. Matsukawa, M. Uesaka, Cellular uptake of gold nanoparticles into normal and cancer cells, IFMBE Proc. 25 (2009) 202–205. https://doi.org/10.1007/978-3-642-03887-7_56.
[38] J.D. Trono, K. Mizuno, N. Yusa, T. Matsukawa, K. Yokoyama, M. Uesaka, Size, concentration and incubation time dependence of gold nanoparticle uptake into pancreas cancer cells and itsfuture application to X-ray drug delivery system, J. Radiat. Res. 52 (2011) 103–109. https://doi.org/10.1269/jrr.10068.
[39] E.A. Britta, D.B. Scariot, H. Falzirolli, T. Ueda-Nakamura, C.C. Silva, B.P.D. Filho, R. Borsali, C.V. Nakamura, Cell death and ultrastructural alterations in Leishmania amazonensis caused by new compound 4-Nitrobenzaldehyde thiosemicarbazone derived from S-limonene, BMC Microbiol. 14 (2014) 236. https://doi.org/10.1186/s12866-014-0236-0.
[40] M. Sechi, V. Sanna, N. Pala, P. Manconi, A. Mariani, S. Dedola, M. Rassu, C. Crosio, C. Iaccarino, G. Dessi, Single-step green synthesis and characterization of gold-conjugated polyphenol nanoparticles with&nbsp;antioxidant&nbsp;and biological activities, Int. J. Nanomedicine. 9 (2014) 4935. https://doi.org/10.2147/IJN.S70648.
[41] A. Badirzadeh, T. Taheri, Y. Taslimi, Z. Abdossamadi, M. Heidari-Kharaji, E. Gholami, B. Sedaghat, M. Niyyati, S. Rafati, Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites, PLoS Negl. Trop. Dis. 11 (2017) 1–22. https://doi.org/10.1371/journal.pntd.0005774.
[42] S. Mondal, P. Roy, S. Das, A. Halder, A. Mukherjee, T. Bera, In Vitro susceptibilities of wild and drug resistant Leishmania donovani amastigote stages to andrographolide nanoparticle: Role of vitamin e derivative TPGS for nanoparticle efficacy, PLoS One. 8 (2013). https://doi.org/10.1371/journal.pone.0081492.
[43] I.M. Corraliza, M.L. Campo, G. Soler, M. Modolell, Determination of arginase activity in macrophages: a micromethod, J. Immunol. Methods. 174 (1994) 231–235. https://doi.org/10.1016/0022-1759(94)90027-2.
[44] J.M. Boitz, C.A. Gilroy, T.D. Olenyik, D. Paradis, J. Perdeh, K. Dearman, M.J. Davis, P.A. Yates, Y. Li, M.K. Riscoe, B. Ullman, S.C. Roberts, Arginase is essential for survival of Leishmania donovani promastigotes but not intracellular amastigotes, Infect. Immun. 85 (2017) 1–14. https://doi.org/10.1128/IAI.00554-16.
[45] D. Resistance, In Vitro Evaluation of Antileishmanial Activity of Computationally Screened Compounds against Ascorbate, 61 (2017) 1–25.
[46] F. Chappuis, S. Sundar, A. Hailu, H. Ghalib, S. Rijal, R.W. Peeling, J. Alvar, M. Boelaert, Visceral leishmaniasis: What are the needs for diagnosis, treatment and control?, Nat. Rev. Microbiol. 5 (2007) 873–882. https://doi.org/10.1038/nrmicro1748.
[47] O.P. Singh, E. Hasker, M. Boelaert, S. Sundar, Elimination of visceral leishmaniasis on the Indian subcontinent, Lancet Infect. Dis. 16 (2016) e304–e309. https://doi.org/10.1016/S1473-3099(16)30140-2.
[48] Y. Mueller, A. Nguimfack, P. Cavailler, S. Couffignal, J.B. Rwakimari, L. Loutan, F. Chappuis, Safety and effectiveness of amphotericin B deoxycholate for the treatment of visceral leishmaniasis in Uganda, Ann. Trop. Med. Parasitol. 102 (2008) 11–19. https://doi.org/10.1179/136485908X252142.
[49] S. Sundar, P.K. Sinha, M. Rai, D.K. Verma, K. Nawin, S. Alam, J. Chakravarty, M. Vaillant, N. Verma, K. Pandey, P. Kumari, C.S. Lal, R. Arora, B. Sharma, S. Ellis, N. Strub-Wourgaft, M. Balasegaram, P. Olliaro, P. Das, F. Modabber, Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: An open-label, non-inferiority, randomised controlled trial, Lancet. 377 (2011) 477–486. https://doi.org/10.1016/S0140-6736(10)62050-8.
[50] S. Mistro, B. Gomes, L. Rosa, L. Miranda, M. Camargo, R. Badaró, Cost-effectiveness of liposomal amphotericin B in hospitalised patients with mucocutaneous leishmaniasis, Trop. Med. Int. Heal. 22 (2017) 1569–1578. https://doi.org/10.1111/tmi.12996.
[51] H.H.L. Borba, L.M. Steimbach, B.S. Riveros, F.S. Tonin, V.L. Ferreira, B.A. de Q. Bagatim, G. Balan, R. Pontarolo, A. Wiens, Cost-effectiveness of amphotericin B formulations in the treatment of systemic fungal infections, Mycoses. 61 (2018) 754–763. https://doi.org/10.1111/myc.12801.
[52] M. Salem, K. Werbovetz, Natural Products from Plants as Drug Candidates and Lead Compounds Against Leishmaniasis and Trypanosomiasis, Curr. Med. Chem. 13 (2006) 2571–2598. https://doi.org/10.2174/092986706778201611.
[53] T.J. Schmidt, S.A. Khalid, A.J. Romanha, T.MA. Alves, M.W. Biavatti, R. Brun, F.B. Da Costa, S.L. de Castro, V.F. Ferreira, M.V.G. de Lacerda, J.H.G. Lago, L.L. Leon, N.P. Lopes, R.C. das Neves Amorim, M. Niehues, I.V. Ogungbe, The Potential of Secondary Metabolites from Plants as Drugs or Leads Against Protozoan Neglected Diseases - Part I, Curr. Med. Chem. 19 (2012) 2128–2175. https://doi.org/10.2174/092986712800229023.
[54] N. Kar, S. Chakraborty, A.K. De, S. Ghosh, T. Bera, Development and evaluation of a cedrol-loaded nanostructured lipid carrier system for in vitro and in vivo susceptibilities of wild and drug resistant Leishmania donovani amastigotes, Eur. J. Pharm. Sci. 104 (2017) 196–211. https://doi.org/10.1016/j.ejps.2017.03.046.
[55] S. Das, A. Halder, S. Mandal, M.A.J. Mazumder, T. Bera, A. Mukherjee, P. Roy, Andrographolide engineered gold nanoparticle to overcome drug resistant visceral leishmaniasis, Artif. Cells, Nanomedicine Biotechnol. 46 (2018) 751–762. https://doi.org/10.1080/21691401.2018.1435549.
[56] A.W. English, K. Liu, J.M. Nicolini, A.M. Mulligan, K. Ye, Small-molecule trkB agonists promote axon regeneration in cut peripheral nerves, Proc. Natl. Acad. Sci. U. S. A. 110 (2013) 16217–16222. https://doi.org/10.1073/pnas.1303646110.
[57] I.L.K. Wong, K.F. Chan, B.A. Burkett, Y. Zhao, Y. Chai, H. Sun, T.H. Chan, L.M.C. Chow, Flavonoid dimers as bivalent modulators for pentamidine and sodium stiboglucanate resistance in Leishmania, Antimicrob. Agents Chemother. 51 (2007) 930–940. https://doi.org/10.1128/AAC.00998-06.
[58] A. Mukherjee, P.K. Padmanabhan, S. Singh, G. Roy, I. Girard, M. Chatterjee, M. Ouellette, R. Madhubala, Role of ABC transporter MRPA, γ-glutamylcysteine synthetase and ornithine decarboxylase in natural antimony-resistant isolates of Leishmania donovani, J. Antimicrob. Chemother. 59 (2007) 204–211. https://doi.org/10.1093/jac/dkl494.
[59] L.C. Manjolin, M.B.G. Dos Reis, C. Do Carmo Maquiaveli, O.A. Santos-Filho, E.R. Da Silva, Dietary flavonoids fisetin, luteolin and their derived compounds inhibit arginase, a central enzyme in Leishmania (Leishmania) amazonensis infection, Food Chem. 141 (2013) 2253–2262. https://doi.org/10.1016/j.foodchem.2013.05.025.
[60] Arnida, M.M. Janát-Amsbury, A. Ray, C.M. Peterson, H. Ghandehari, Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages, Eur. J. Pharm. Biopharm. 77 (2011) 417–423. https://doi.org/10.1016/j.ejpb.2010.11.010.
[61] K. Jomová, L. Hudecova, P. Lauro, M. Simunkova, S.H. Alwasel, I.M. Alhazza, M. Valko, A switch between antioxidant and prooxidant properties of the phenolic compounds myricetin, morin, 3’,4’-dihydroxyflavone, taxifolin and 4-hydroxy-coumarin in the presence of copper(II) ions: A spectroscopic, absorption titration and DNA damage study, Molecules. 24 (2019). https://doi.org/10.3390/molecules24234335.
[62] J.I. Aoki, S.M. Muxel, R.A. Zampieri, S.M. Acuña, J.C.R. Fernandes, R.H. Vanderlinde, M.C.O. de P. Sales, L.M. Floeter-Winter, L-arginine availability and arginase activity: Characterization of amino acid permease 3 in Leishmania amazonensis, PLoS Negl. Trop. Dis. 11 (2017). https://doi.org/10.1371/journal.pntd.0006025.
[63] V. Iniesta, L.C. Gómez-Nieto, I. Corraliza, The inhibition of arginase by Nω-hydroxy-L-arginine controls the growth of Leishmania inside macrophages, J. Exp. Med. 193 (2001) 777–783. https://doi.org/10.1084/jem.193.6.777.
[64] S.C. Roberts, M.J. Tancer, M.R. Polinsky, K. Michael Gibson, O. Heby, B. Ullman, Arginase plays a pivotal role in polyamine precursor metabolism in Leishmania: Characterization of gene deletion mutants, J. Biol. Chem. 279 (2004) 23668–23678. https://doi.org/10.1074/jbc.M402042200.
[65] S. Gordon, Alternative activation of macrophages, Nat. Rev. Immunol. 3 (2003) 23–35. https://doi.org/10.1038/nri978.
[66] T. Walle, Methylation of dietary flavones greatly improves their hepatic metabolic stability and intestinal absorption, Mol. Pharm. 4 (2007) 826–832. https://doi.org/10.1021/mp700071d.
[67] C.C. Yen, C.W. Chang, M.C. Hsu, Y.T. Wu, Self-Nanoemulsifying drug delivery system for resveratrol: Enhanced oral bioavailability and reduced physical fatigue in rats, Int. J. Mol. Sci. 18 (2017). https://doi.org/10.3390/ijms18091853.
[68] Z. Zhang, Y. Huang, F. Gao, Z. Gao, H. Bu, W. Gu, Y. Li, A self-assembled nanodelivery system enhances the oral bioavailability of daidzein: In vivo characteristics and in vivo performance, Nanomedicine. 6 (2011) 1365–1379. https://doi.org/10.2217/nnm.11.39.
[69] A. Anwar, S. Khalid, S. Perveen, S. Ahmed, R. Siddiqui, N.A. Khan, M.R. Shah, Synthesis of 4-(dimethylamino)pyridine propylthioacetate coated gold nanoparticles and their antibacterial and photophysical activity, J. Nanobiotechnology. 16 (2018). https://doi.org/10.1186/s12951-017-0332-z.
[70] T.G. Ribeiro, M.A. Chávez-Fumagall, D.G. Valadares, J.R. França, L.B. Rodrigues, M.C. Duarte, P.S. Lage, P.H.R. Andrade, D.P. Lage, L. V. Arruda, C. Refidaff, L.E. Costa, V.T. Martins, C.A.P. Tavares, R.O. Castilho, E.A.F. Coelho, A.A.G. Faraco, Novel targeting using nanoparticles: An approach to the development of an effective anti-leishmanial drug-delivery system, Int. J. Nanomedicine. 9 (2014) 877–890. https://doi.org/10.2147/IJN.S55678.
[71] N. Bruni, B. Stella, L. Giraudo, C. Della Pepa, D. Gastaldi, F. Dosio, Nanostructured delivery systems with improved leishmanicidal activity: A critical review, Int. J. Nanomedicine. 12 (2017) 5289–5311. https://doi.org/10.2147/IJN.S140363.
[72] E. Riley, S.C. Roberts, B. Ullman, Inhibition profile of Leishmania mexicana arginase reveals differences with human arginase I, Int. J. Parasitol. 41 (2011) 545–552. https://doi.org/10.1016/j.ijpara.2010.12.006.
[73] E.L. D’Antonio, B. Ullman, S.C. Roberts, U.G. Dixit, M.E. Wilson, Y. Hai, D.W. Christianson, Crystal structure of arginase from Leishmania mexicana and implications for the inhibition of polyamine biosynthesis in parasitic infections, Arch. Biochem. Biophys. 535 (2013) 163–176. https://doi.org/10.1016/j.abb.2013.03.015.
[74] P. Kropf, J.M. Fuentes, E. Fähnrich, L. Arpa, S. Herath, V. Weber, G. Soler, A. Celada, M. Modolell, I. Müller, Arginase and polyamine synthesis are key factors in the regulation of experimental leishmaniasis in vivo, FASEB J. 19 (2005) 1000–1002. https://doi.org/10.1096/fj.04-3416fje.